Yanyu Wu

Real-World Treatment Patterns and Progression-Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for <i>ALK+</i> Non-Small Cell Lung Cancer

Mohammad Jahanzeb, Huamao Mark Lin, Xiaoyun Pan et al. · The Oncologist · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States

Huamao Mark Lin, Yu Yin, Victoria Crossland et al. · JTO Clinical and Research Reports · 2022 · 26 citations · Full text

Medicine, Molecular Genetics, Molecular Medicine +12

Association Between Breast Cancer Disease Progression and Workplace Productivity in the United States

Wesley Yin, Ruslan Horblyuk, Julia Jane Perkins et al. · Journal of Occupational and Environmental Medicine · 2017 · 23 citations

Medicine, Oncology, Breast Oncology +13

Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors

Huamao Mark Lin, Xiaoyun Pan, Peijie Hou et al. · Journal of Medical Economics · 2020 · 19 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +15

The option value of innovative treatments for non-small cell lung cancer and renal cell carcinoma.

Julia Thornton Snider, Katharine Batt, Yanyu Wu et al. · PubMed · 2017 · 18 citations

Medicine, Oncology, Pharmacotherapy +17